Add to MyYahoo RSS

Biotech News

Biotech news continually updated from thousands of sources around the net.

2 hrs ago | Reuters

AbbVie urges U.S. court to avoid gay rights issue in HIV drug case

An Abbott Laboratories spinoff urged a federal appeals court to revisit a ruling in a case against GlaxoSmithKline Plc, but without disturbing landmark constitutional protections for gays and lesbians.


Related Topix: Gay/Lesbian, HIV/AIDS, Health, Facet Biotech, Medicine, GlaxoSmithKline, Healthcare Industry, US News, Ninth Circuit Court of Appeals

6 hrs ago | Brandon Sun

Condiment maker Tessemae's gets professional help and is now dressed for success

When Tessemae's salad dressing quickly became a hit, the owners of the family-run condiment company were faced with the reality that they needed help navigating the grocery business.


Related Topix: Medifast, Medicine, Healthcare Industry

10 hrs ago | ABC News

Court Declines to Block Drug Ruling in Patent Case

Supreme Court Chief Justice John Roberts on Friday declined to temporarily block a lower court ruling that opens the world's best-selling multiple sclerosis drug to competition from generic rivals next month.


Related Topix: US News, John G. Roberts, Teva Pharmaceutical Industries, Federal Circuit Court of Appeals

12 hrs ago | Reuters

Exclusive: Biogen prices hemophilia drug on par with older therapies

Biogen Idec Inc is pricing its newly-approved long-acting hemophilia drug to cost U.S. patients, and insurers, about the same per year as older, less convenient therapies whose price can reach about $300,000 annually.


Related Topix: Hemophilia, Health, Pfizer, Medicine, Healthcare Industry

17 hrs ago |

Unemployment rates fall in 21 US states last month

More than two-thirds of the states reported job gains in March, as hiring improves for much of the country during what has been a sluggish but sustained 4 1/2-year recovery.


Related Topix: Centers for Disease Control and Prevention, Medicine, Healthcare Industry

21 hrs ago | The Motley Fool

If This Biotech Drops Much Further I'm Going to Buy It

We've seen a little bit of a relief rally over the past couple of days in the overall market with the start of earnings season giving investors hope that the U.S. economy and corporations can keep motoring higher.


Related Topix: Financial Markets, Medicine, Gilead Sciences, Healthcare Industry, Hepatitis, Health

Thu Apr 17, 2014

Norwalk Citizen News

Rice students work to bring deft touch to amputees

When picking up a delicate egg, they can't instinctively modulate how hard they're gripping it.


Related Topix: Rice University, Science / Technology, Texas, Inventions


Teva, Pfizer settle patent lawsuit over painkiller Celebrex

Teva Pharmaceutical Industries Ltd said it settled a patent litigation with Pfizer Inc, allowing the Israeli drugmaker to launch a generic version of Pfizer's blockbuster pain medication, Celebrex, in December.


Related Topix: Pfizer, Teva Pharmaceutical Industries, Medicine, Healthcare Industry, Celebrex, Celecoxib (generic), Pharmaceuticals, Health, Pain


FDA OKs Merck Tablet to Reduce Ragweed Allergies

U.S. regulators have again approved a Merck & Co. tablet for gradually reducing seasonal allergies, this time for ragweed pollen.


Related Topix: Merck , Medicine, Healthcare Industry, Merck & Co., Whitehouse Station, NJ


GSK, facing bribery claims, battles to build new sales model

Drugmaker GlaxoSmithKline - hit by bribery claims in five countries - is to employ hundreds more doctors as members of staff as it seeks to build a new sales model designed to eliminate sharp marketing practices.


Related Topix: Medicine, GlaxoSmithKline, Marketing

WCAX-TV Burlington

NY-based co. closing Syracuse-area lab in July

An Albany-based pharmaceutical company that's part of a $250 million economic development project in Buffalo is shutting down its Syracuse-area research center, eliminating 45 jobs.


Related Topix: Albany Molecular Research, Medicine, Healthcare Industry, Cedarburg, WI


UPDATE 1-GSK says investigating claims of bribery in Jordan, Lebanon

GlaxoSmithKline, Britain's biggest drugmaker, said on Wednesday it was investigating allegations of bribery involving some of its staff in Jordan and Lebanon, following earlier claims of corruption in China, Poland and Iraq.


Related Topix: GlaxoSmithKline, Marketing


Galapagos, GSK successfully conclude phase 2a study of skin disease drug

Belgian biotech group Galapagos NV on Thursday said it has successfully concluded the phase 2a study of a skin disease drug it is developing with Britain's GlaxoSmithKline PLC.


Related Topix: GlaxoSmithKline

Wed Apr 16, 2014

Study: Diabetic heart attacks and strokes falling

In this Friday, March 1, 2013 file photo, Chan Lai Ly, right, has his mouth examined by Honghue Duong, a physician's assistant, as part of a regular check-up related to his diabetes at International Community Health Services in Seattle.


Related Topix: Medicine, Diabetes, Health, Centers for Disease Control and Prevention, Healthcare Industry, Epidemic, Natural Disasters


Vermont Senate passes mandatory GMO food-labeling law

The Vermont Senate passed a bill on Wednesday that would make the state the first in the United States to enact mandatory labeling of foods made with genetically modified crops.


Related Topix: Agriculture, Science

ABC News

Smartphone Apps to Help Patients Take Their Meds

Several smartphone apps are available to help patients take their medications as prescribed.


Related Topix: Johnson & Johnson, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Advanced Transit Dynamics, VisionCare Ophthalmic Technologies, Startups, Johnson Controls

Nanaimo Daily News

GlaxoSmithKline says it is looking into new bribery allegations in Jordan and ...

The company said Wednesday that it started looking into the conduct of "a small number of individuals" in December.


Related Topix: GlaxoSmithKline, Medicine, Healthcare Industry

Investor's Business Daily

Dr. Reddy's Announces the Launch of Eszopiclone Tablets C-IV

Dr. Reddy's Laboratories announced today that it has launched Eszopiclone Tablets 1 mg, 2 mg and 3 mg, a therapeutic equivalent generic version of LUNESTAA tablets C-IV in the US market on April 15, 2014, following the approval by the United States Food & Drug Administration .


Related Topix: Dr Reddys Laboratories

MSN Money

Stock futures tick up after earnings, prices data due

Stock index futures edged up on Tuesday after earnings from Coca Cola and Johnson & Johnson and ahead of economic data including inflation and manufacturing.


Related Topix: Beverages, CocaCola, Johnson & Johnson, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Terrorism

Tue Apr 15, 2014

The Beaumont Enterprise

Asia shares rise, shrug off slower China growth

World markets turned lower on Tuesday amid concerns about instability in Ukraine, the value of technology stocks and an economic slowdown in China.


Related Topix: Financial Markets, Johnson & Johnson, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry


Biotech Jobs